129 related articles for article (PubMed ID: 29468218)
1. Intravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma.
Vale S; Montalvo L; Baez E; Oliver AL
Am J Ophthalmol Case Rep; 2018 Mar; 9():45-47. PubMed ID: 29468218
[TBL] [Abstract][Full Text] [Related]
2. A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma.
Hidaka T; Chuman H; Nao-I N
Case Rep Ophthalmol; 2018; 9(2):401-404. PubMed ID: 30283326
[TBL] [Abstract][Full Text] [Related]
3. INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS.
Seidman CJ; Finger PT; Silverman JS; Oratz R
Retin Cases Brief Rep; 2017 Winter; 11(1):47-50. PubMed ID: 26862924
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
[TBL] [Abstract][Full Text] [Related]
5. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report.
Sothornwit N
J Med Assoc Thai; 2008; 91 Suppl 1():S162-5. PubMed ID: 18672609
[TBL] [Abstract][Full Text] [Related]
7. Use of Intravitreal Bevacizumab for the Treatment of Secondary Glaucoma Caused by Metastatic Iris Tumor.
Aydin R; Tezel TH
J Glaucoma; 2018 Jun; 27(6):e113-e116. PubMed ID: 29613980
[TBL] [Abstract][Full Text] [Related]
8. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Batioğlu F; Astam N; Ozmert E
Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal Ranibizumab as Palliative Therapy for Iris Metastasis Complicated With Refractory Secondary Glaucoma.
Makri OE; Psachoulia C; Exarchou A; Georgakopoulos CD
J Glaucoma; 2016 Jan; 25(1):e53-5. PubMed ID: 25304284
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome.
Lee SJ; Lee JJ; Kim SY; Kim SD
Korean J Ophthalmol; 2009 Jun; 23(2):132-4. PubMed ID: 19568367
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma.
Marey HM; Ellakwa AF
Clin Ophthalmol; 2011; 5():841-5. PubMed ID: 21750619
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma.
Ghanem AA; El-Kannishy AM; El-Wehidy AS; El-Agamy AF
Middle East Afr J Ophthalmol; 2009 Apr; 16(2):75-9. PubMed ID: 20142965
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab for ocular metastasis of multiple myeloma.
Zhou Q; Liang J; Lu H
Optom Vis Sci; 2013 Sep; 90(9):e236-40; discussion 1028. PubMed ID: 23811608
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Intravitreal Bevacizumab Injection on Iris and Iridocorneal Angle Neovascularization in Neovascular Glaucoma].
Ishibashi S; Kondo H
J UOEH; 2015 Dec; 37(4):299-304. PubMed ID: 26667197
[TBL] [Abstract][Full Text] [Related]
16. Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma.
Canut MI; Alvarez A; Nadal J; Abreu R; Abreu JA; Pulido JS
Clin Ophthalmol; 2011; 5():715-9. PubMed ID: 21629579
[TBL] [Abstract][Full Text] [Related]
17. [Intravitreal bevacizumab in the treatment of neovascular glaucoma].
Ouhadj O; Chergui I; Mendil L; Nouri MT
J Fr Ophtalmol; 2009 Feb; 32(2):112-6. PubMed ID: 20579473
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab (Avastin) for the management of anterior chamber neovascularization and neovascular glaucoma.
Brouzas D; Charakidas A; Moschos M; Koutsandrea C; Apostolopoulos M; Baltatzis S
Clin Ophthalmol; 2009; 3():685-8. PubMed ID: 20054417
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab for neovascular glaucoma.
Andrijević-Derk B; Vatavuk Z; Bencić G; Novak-Laus K; Mandić Z
Acta Clin Croat; 2008 Sep; 47(3):175-9. PubMed ID: 19175068
[TBL] [Abstract][Full Text] [Related]
20. The use of intravitreal bevacizumab in neovascular glaucoma: a case report.
Kelkar AS; Kelkar SB; Kelkar JA; Nagpal M; Patil SP
Bull Soc Belge Ophtalmol; 2007; (303):43-5. PubMed ID: 17894286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
